Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$59.60 USD

59.60
22,361,140

+3.56 (6.35%)

Updated May 31, 2024 04:00 PM ET

After-Market: $59.55 -0.05 (-0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 4% (239 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

CVS Health (CVS) to Report Q1 Earnings: What's in the Cards?

CVS Health's (CVS) digital capabilities are expected to have driven consumer engagement across all CVS Health businesses in Q1.

Analysts Estimate CVS Health (CVS) to Report a Decline in Earnings: What to Look Out for

CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Industry Outlook Highlights CVS Health, Walgreens BootsAlliance, Rite Aid and Amazon

CVS Health, Walgreens BootsAlliance, Rite Aid and Amazon have been highlighted in this Industry Outlook article.

Urmimala Biswas headshot

3 Retail Pharmacy and Drugstore Stocks to Watch in a Growing Industry

Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain on the strength of their digital pharmacies.

CVS Health (CVS) Dips More Than Broader Markets: What You Should Know

CVS Health (CVS) closed the most recent trading day at $73.25, moving -1.29% from the previous trading session.

Rite Aid (RAD) Reports Q4 Loss, Tops Revenue Estimates

Rite Aid (RAD) delivered earnings and revenue surprises of -61.04% and 6.90%, respectively, for the quarter ended February 2023. Do the numbers hold clues to what lies ahead for the stock?

CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet

The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

CVS Health (CVS) Dips More Than Broader Markets: What You Should Know

CVS Health (CVS) closed the most recent trading day at $74.92, moving -1.8% from the previous trading session.

CVS Health (CVS) Team Up to Treat Digestive Disorder Virtually

CVS Health's (CVS) recent partnership with Oshi makes it possible for its members to receive coordinated virtual digestive treatment.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

CVS Health (CVS) closed at $77.54 in the latest trading session, marking a -0.27% move from the prior day.

Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

CVS Health's (CVS) New Initiatives Aid, Margin Woes Linger

CVS Health (CVS) launches functionality that gives patients more choices and convenience in filling prescriptions.

CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

CVS Health (CVS) closed at $74.70 in the latest trading session, marking a +0.82% move from the prior day.

Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?

According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

CVS Health (CVS) Nears Completion of $8B SGFY Acquisition

According to CVS Health (CVS), Signify Health, a leading healthcare platform, is set to play a critical role in advancing its healthcare services strategy.

Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

CVS Health (CVS) Stock Moves -1.52%: What You Should Know

CVS Health (CVS) closed the most recent trading day at $74.41, moving -1.52% from the previous trading session.

CVS Health (CVS) Gains But Lags Market: What You Should Know

CVS Health (CVS) closed at $75.83 in the latest trading session, marking a +0.57% move from the prior day.

Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It?

The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Shaun Pruitt headshot

Should Investors Buy Bristol Myers or CVS Stock Near 52-week Lows?

Investors are often on the lookout for strong companies that may be undervalued and present lucrative long-term opportunities.

CVS Health (CVS) Gains As Market Dips: What You Should Know

CVS Health (CVS) closed at $77.10 in the latest trading session, marking a +0.13% move from the prior day.

CVS Health (CVS) Down 14.5% Since Last Earnings Report: Can It Rebound?

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain CVS Health (CVS) Stock for Now

Investors are optimistic about CVS Health (CVS), backed by the announcement of entering into a colossal $10.6-billion acquisition agreement to purchase Oak Street Health.